- Health-care dealmaking picking up again after 2024 slump
- Intra-Cellular develops treatments for mental health disorders
Johnson & Johnson is in talks to acquire Intra-Cellular Therapies Inc., a biopharmaceutical company focused on treatments for central nervous system disorders, people familiar with the matter said.
A deal could be reached as soon as this week, according to the people, who asked not to be identified discussing confidential information. While discussions are ongoing, they may not lead to an agreement and other suitors could also emerge, they said.
https://www.bloomberg.com/news/articles/2025-01-12/johnson-johnson-exploring-bid-for-intra-cellular
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.